Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial
Article in Frontiers in Gastroenterology (January 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Article in Frontiers in Gastroenterology (January 2024)
Book chapter (January 2024)
Article in Aquaculture (January 2024)